Verition Fund Management
OPTN

Verition Fund Management’s OptiNose OPTN Stock Holding History

Verition Fund Management’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,727
Closed -$167K – 3435
2024
Q2 		$167K Buy
+10,727
New +$180K ﹤0.01% 2647

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Verition Fund Management's OPTN Position: Q3 2024 in Review

Verition Fund Management sold out of OptiNose (OPTN) in Q3 2024, closing a stake of 10,727 shares — an estimated $167K sold.

Verition Fund Management first reported a position in OPTN in Q2 2024 and held it in 1 quarter. The position peaked at $167K in Q2 2024. 65 funds tracked by Wall St. Rank hold OPTN as of Q3 2024.

  • Verition Fund Management reported no remaining OptiNose position as of Q3 2024 after selling out during the quarter.
  • Verition Fund Management sold 10,727 OptiNose shares in Q3 2024, an estimated $167K.
  • Verition Fund Management first reported a position in OptiNose in Q2 2024 and held it in 1 quarter.
  • Verition Fund Management's OptiNose position peaked at $167K in Q2 2024.
  • 65 funds tracked by Wall St. Rank held OptiNose as of Q3 2024.

Based on Verition Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.